These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 6278563)

  • 21. Drug resistant tuberculosis in Estonia.
    Kruuner A; Sillastu H; Danilovitsh M; Levina K; Svenson SB; Källenius G; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):130-3. PubMed ID: 9562123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-resistance of Mycobacterium tuberculosis in time.
    Mazzei L; Croce GF; Zarzana A; Biagioli D; Sposato B; Pulcinelli A
    Eur Rev Med Pharmacol Sci; 1998; 2(1):21-4. PubMed ID: 9825566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Incidence of tuberculostatic-resistant Mycobacterium tuberculosis. Clinical aspects and impact on therapy and clinical course].
    Esteban J; Gegúndez MI; García-Corbeira P; Soriano F
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):415-9. PubMed ID: 8260512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemoresistance of mycobacteria in a group of patients with tuberculosis from Mureş county].
    Tarcea M; Toma F; Patraulea M; Nemeş M; Tokés C; Sabău M; Golea C
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(1-2):29-36. PubMed ID: 18441956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005.
    Mokaddas E; Ahmad S; Samir I
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):319-25. PubMed ID: 18284839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
    Vojtek J; Holecková R; Rozánek R; Starosta V; Strnad M; Sebests J; Strusa V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965; 8(5):589-92. PubMed ID: 4955225
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
    Shaĭkhaev AIa; Naumov VN
    Probl Tuberk; 2000; (4):24-6. PubMed ID: 10981427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary mycobacterial resistance and its relations to the clinical aspects and therapy of tuberculosis].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1967 Jun; 22(6):519-34. PubMed ID: 4973216
    [No Abstract]   [Full Text] [Related]  

  • 30. [A study on prevalence of resistance to primary and secondary drugs among newly admitted pulmonary tuberculosis patients in 1977. Part 2. Studies on the factors related to the prevalence of drug resistance (author's transl)].
    Gomi J; Chiba Y; Yanagisawa K
    Kekkaku; 1979 Dec; 54(12):549-55. PubMed ID: 118299
    [No Abstract]   [Full Text] [Related]  

  • 31. [Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
    Med Clin (Barc); 1996 Jan; 106(1):1-6. PubMed ID: 8750533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug resistance of Mycobacterium tuberculosis in the Sunamganj District of Bangladesh.
    Storla DG; Rahim Z; Islam MA; Plettner S; Begum V; Myrvang B; Bjune G; Rønnild E; Dahle UR; Mannsåker T
    Scand J Infect Dis; 2007; 39(2):142-5. PubMed ID: 17366031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
    Cox HS; Niemann S; Ismailov G; Doshetov D; Orozco JD; Blok L; Rüsch-Gerdes S; Kebede Y
    Clin Infect Dis; 2007 Jun; 44(11):1421-7. PubMed ID: 17479936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current bacteriologic and clinical aspects of chemo-antibiotic therapy of pulmonary tuberculosis].
    Saltini C; Velluti G; Mantovani P
    Arch Monaldi; 1978; 33(4):251-79. PubMed ID: 116622
    [No Abstract]   [Full Text] [Related]  

  • 36. [Incidence of primary resistance to antitubercular agents in the Toulouse area].
    Puel J; Galtier M; Lareng MB; Delaude A
    Arch Monaldi; 1972; 27(4):418-25. PubMed ID: 4217598
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acquired resistance of M tuberculosis to the antitubercular drugs in Chile from 1988 to 1991].
    Guzmán AM; García P; Valenzuela MT; Piffardi S; Lepe R; Velasco M; Vergara MI
    Rev Med Chil; 1993 Nov; 121(11):1269-73. PubMed ID: 8191133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens.
    Van Deun A; Aung KJ; Chowdhury S; Saha S; Pankaj A; Ashraf A; Rigouts L; Fissette K; Portaels F
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):143-8. PubMed ID: 10091880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial and acquired drug resistance of Mycobacterium tuberculosis in east Delhi.
    Mahajan M; Agarwal DS; Gadre DJ; Singh NP; Gupta HC; Talwar V
    J Commun Dis; 1996 Mar; 28(1):15-9. PubMed ID: 8778175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary resistance of tubercle bacillus to standard drugs (incidence in Recife)].
    Magalhães M
    Rev Bras Med; 1969 Jul; 26(7):395-7. PubMed ID: 4981470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.